Viemed Healthcare (VMD) Change in Accured Expenses (2018 - 2026)
Viemed Healthcare (VMD) posted Change in Accured Expenses of -$2.6 million for Q1 2026, down 95.79% on a QoQ basis from -$1.3 million in Q4 2025, and up 14.69% year-over-year from -$2.3 million in Q1 2025.
Viemed Healthcare (VMD) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Viemed Healthcare's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- Quarterly Change in Accured Expenses rose 14.69% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $703000.0 (down 79.56% YoY) and the FY2025 annual result came in at $255000.0, down 91.07% from the prior year.
- Change in Accured Expenses was -$2.6 million for Q1 2026 at Viemed Healthcare, down from -$1.3 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.6 million in Q3 2025 and bottomed at -$3.6 million in Q1 2024.
- A 5-year average of $471647.1 and a median of $433000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 3559.55% — and 2025, when it tumbled 406.93%.
- Viemed Healthcare's Change in Accured Expenses stood at -$621000.0 in 2022, then soared by 240.58% to $873000.0 in 2023, then plunged by 50.4% to $433000.0 in 2024, then tumbled by 406.93% to -$1.3 million in 2025, then tumbled by 95.79% to -$2.6 million in 2026.
- Business Quant data shows VMD's Change in Accured Expenses at -$2.6 million in Q1 2026, -$1.3 million in Q4 2025, and $3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | -2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.60 Mn |
| Mar 31, 2026 | -2.60 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Sep 30, 2025 | 3.56 Mn |
| Sep 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | -3.05 Mn |
| Mar 31, 2025 | -3.05 Mn |
| Dec 31, 2024 | 433,000.00 |
| Dec 31, 2024 | 433,000.00 |
| Sep 30, 2024 | 3.33 Mn |
| Sep 30, 2024 | 3.33 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Mar 31, 2024 | -3.63 Mn |
| Mar 31, 2024 | -3.63 Mn |
| Dec 31, 2023 | 873,000.00 |
| Dec 31, 2023 | 873,000.00 |